The House of Representatives last week approved a provisional measure that makes it mandatory for health plans to cover oral cancer drugs.
According to the approved rules, in order for the patient to be able to demand the offer of the drug, he must present the medical prescription and that the drug has been registered with the National Health Surveillance Agency (Anvisa) and included in the list of obligations of the plans defined by the Agency. National Supplementary Health (ANS). The MP establishes a period of 120 days, extendable by 60, for the ANS to analyze the inclusion of oral cancer drugs.
In this episode of E Tem Mais, Carol Nogueira presents an assessment of the reactions to the approval of the proposed new legislation. To describe the possible impacts of the measure and the obstacles faced by those fighting cancer, Ana Paula da Silva Azevedo, who is undergoing treatment for breast cancer, and oncologist Fernando Maluf, founder of the Vencer o Câncer Institute, participate in this episode.
Discover other CNN Brasil podcasts:
Week of 22 – Much more than the modern
Brasilia time
5 facts
To Prioli
between voices
All content on CNN Brasil’s digital grid is free.
(*Posted by Diego Toledo)
Source: CNN Brasil
